$GRAL· News ·

MacroGenics drops after FDA partial clinical hold on lead program

GRAIL, Inc. Common Stock · SERVICES-MEDICAL LABORATORIES · Now $64.40

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS